CellRx is a manufacturer and supplier of growth factors for the technical research and bioprocessing markets. Their flagship product is Short AE-IGF-1, a well-characterized and high-potency alternative to insulin and other insulin-like analogues. Short AE-IGF-1 offers maximum performance at an unbeatable value, matching or exceeding competing growth factors in protein productivity and cell viability. It is produced under strict FDA, EMA, and GMP guidelines, ensuring high quality and comprehensive risk management. CellRx also provides specialist services including GMP contract manufacturing and bioprocess development and optimization, offering expertise in microbial fermentation and process development for research and large-scale production.